{"nct_id":"NCT05593328","title":"Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2023-03-17","start_date_type":"ACTUAL","primary_completion_date":"2024-12-09","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CRDF"]}